The European Medicines Company’s Committee for Medicinal Merchandise for Human Use (CHMP) has advisable the approval of amivantamab-vmjw (Rybrevant) together with carboplatin and...
Erminia Massarelli, MD, PhD, MS, co-director, Lung Most cancers and Thoracic Oncology Program, affiliate professor, Division of Medical Oncology & Therapeutics Analysis, Metropolis...
Karen L. Reckamp, MD, MS, professor of medication, director, Division of Medical Oncology and Lung Institute, Cedars-Sinai Medical Middle, affiliate director, Medical Analysis,...